Dimerix Stock

Dimerix Debt

The Debt of Dimerix (DXB.AX) as of Sep 4, 2026 is 97,500.00 AUD. In the previous year, Debt was 149,700.00 AUD — a change of -34.87% (lower).

Debt

97,500.00AUD

YoY

-34.87%

Last updated:

In 2026, Dimerix's total debt was 97,500.00 AUD, a -34.87% change from the 149,700.00 AUD total debt recorded in the previous year.

The Dimerix Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
0.00 AUD
Jan 1, 2019
0.00 AUD
Jan 1, 2020
1.09 M AUD
Jan 1, 2021
5.09 M AUD
Jan 1, 2022
73,100.00 AUD
Jan 1, 2023
5.96 M AUD
Jan 1, 2024
149,700.00 AUD
Jan 1, 2025
97,500.00 AUD
The Dimerix Debt history
YEARDebtYoY
97,500.00AUD-34.87%
149,700.00AUD-97.49%
5.96 MAUD+8,050.21%
73,100.00AUD-98.56%
5.09 MAUD+365.42%
1.09 MAUD
0.00AUD
0.00AUD
0.00AUD
0.00AUD
0.00AUD
0.00AUD
Access this data via the Eulerpool API

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Debt Details

Understanding Dimerix's Debt Structure

Dimerix's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Dimerix's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Dimerix’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Dimerix’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Dimerix stock

Debt of Dimerix is 97,500.00 AUD in 2026.

Debt of Dimerix changed from 149,700.00 AUD to 97,500.00 AUD, representing a -34.87% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Dimerix since 2006 – with annual values, charts, and detailed analysis.

Debt's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Dimerix historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Dimerix

All Key Metrics — Dimerix